StockData
NEUROONE MEDICAL TECHNOLOGIES Corp logo

NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) stock

NMTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 11/3080% below fair value
$0.71−0.04 (-5.15%)

Close on Nov 17, 2026Market cap $6.43MP/E –Yield –

Neuroone Medical Technologies operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Neuroone Medical Technologies's operating income for the twelve months ending Jun 30, 2026 was -$7.90M. For fiscal 2025 it was -$4.23M. The highest annual figure on record is -$13.73K in fiscal 2012.

Annual operating income

PeriodPeriod endValueChange
FY2025Sep 30, 2025-$4.23M–
FY2024Sep 30, 2024-$11.89M–
FY2023Sep 30, 2023-$11.96M–
FY2022Sep 30, 2022-$10.03M–
FY2021Sep 30, 2021-$10.22M–
FY2020Sep 30, 2020-$4.90M–
FY2017Dec 31, 2017-$3.07M–
FY2016Dec 31, 2016-$32.61K–
FY2015Dec 31, 2015-$30.92K–
FY2014Dec 31, 2014-$35.91K–
FY2013Dec 31, 2013-$25.09K–
FY2012Dec 31, 2012-$13.73K–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026-$2.42M–
Q2 FY2026CQ1 2026Mar 31, 2026-$2.40M–
Q1 FY2026CQ4 2025Dec 31, 2025-$1.71M-199.8%
Q4 FY2025CQ3 2025Sep 30, 2025-$1.37M–
Q3 FY2025CQ2 2025Jun 30, 2025-$1.89M–
Q2 FY2025CQ1 2025Mar 31, 2025-$2.68M–
Q1 FY2025CQ4 2024Dec 31, 2024$1.71M–
Q4 FY2024CQ3 2024Sep 30, 2024-$2.82M–
Q3 FY2024CQ2 2024Jun 30, 2024-$2.79M–
Q2 FY2024CQ1 2024Mar 31, 2024-$2.89M–
Q1 FY2024CQ4 2023Dec 31, 2023-$3.39M–
Q4 FY2023CQ3 2023Sep 30, 2023-$3.16M–
Q3 FY2023CQ2 2023Jun 30, 2023-$3.51M–
Q2 FY2023CQ1 2023Mar 31, 2023-$3.50M–
Q1 FY2023CQ4 2022Dec 31, 2022-$1.78M–
Q4 FY2022CQ3 2022Sep 30, 2022-$1.40M–
Q3 FY2022CQ2 2022Jun 30, 2022-$2.76M–
Q2 FY2022CQ1 2022Mar 31, 2022-$3.06M–
Q1 FY2022CQ4 2021Dec 31, 2021-$2.81M–
Q4 FY2021CQ3 2021Sep 30, 2021-$2.64M–
Q3 FY2021CQ2 2021Jun 30, 2021-$3.03M–
Q2 FY2021CQ1 2021Mar 31, 2021-$2.40M–
Q1 FY2021CQ4 2020Dec 31, 2020-$2.14M–
Q4 FY2020CQ3 2020Sep 30, 2020-$117.43K–
Q3 FY2020CQ2 2020Jun 30, 2020-$1.59M–
Q2 FY2020CQ1 2020Mar 31, 2020-$1.38M–
Q1 FY2020CQ4 2019Dec 31, 2019-$1.81M–
Q4 FY2017CQ4 2017Dec 31, 2017-$773.78K–
Q3 FY2017CQ3 2017Sep 30, 2017-$893.79K–
Q2 FY2017CQ2 2017Jun 30, 2017-$888.69K–
Q1 FY2017CQ1 2017Mar 31, 2017-$516.06K–
Q4 FY2016CQ4 2016Dec 31, 2016-$65.67K–
Q3 FY2016CQ3 2016Sep 30, 2016-$8.60K–
Q2 FY2016CQ2 2016Jun 30, 2016-$14.11K–
Q1 FY2016CQ1 2016Mar 31, 2016-$4.39K–
Q4 FY2015CQ4 2015Dec 31, 2015-$8.83K–
Q3 FY2015CQ3 2015Sep 30, 2015-$2.59K–
Q2 FY2015CQ2 2015Jun 30, 2015-$18.67K–
Q1 FY2015CQ1 2015Mar 31, 2015-$1.83K–
Q4 FY2014CQ4 2014Dec 31, 2014-$9.88K–

More Neuroone Medical Technologies figures

See a number that looks wrong?